Reckitt Benckiser

Update in progress

RKT.L (LSE)

Company RatingNeutral
SectorConsumer Defensive
IndustryHousehold & Personal Products

Reckitt Benckiser Group plc develops and sells health, hygiene, and nutrition products worldwide. The portfolio includes germ protection with Dettol, intimate wellness with Durex and KY, and over-the-counter medicines such as Nurofen, Gaviscon, Mucinex, Delsym, Strepsils, Cepacol, and Biofreeze. It also covers personal care with Clearasil and Veet, vitamins and supplements (Movefree, Neuriva, MegaRed, Airborne, Digestive-Advantage), stain removal (Vanish), disinfectants (Finish, Harpic, Lysol), and infant nutrition (Enfamil, Nutramigen). Headquartered in Slough, UK.

Company score

Sentiment: 0.50; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.21; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.08; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.05; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.22; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive